Literature DB >> 12175631

Precore and core promoter mutations, hepatitis B virus DNA levels and progressive liver injury in chronic hepatitis B.

Hiroshi Yotsuyanagi1, Kunihiko Hino, Eiichi Tomita, Joji Toyoda, Kiyomi Yasuda, Shiro Iino.   

Abstract

BACKGROUND/AIMS: To elucidate the viral factors responsible for progressive liver injury in chronic hepatitis B.
METHODS: We analyzed 179 persistently infected patients (21 asymptomatic carriers, 126 with chronic hepatitis and 32 with cirrhosis) with genotype C hepatitis B virus (HBV). HBeAg/anti-HBe, levels of HBV DNA, mutations in the basic core promoter (BCP) region at nucleotides 1762/1764 and mutation in the precore (preC) region at nucleotide 1896 were determined. Serial samples from 18 patients also were analyzed.
RESULTS: HBeAg/anti-HBe and HBV DNA levels per se were not related to liver fibrosis. The frequency of BCP mutations increased with progression of liver fibrosis. Although the preC mutation was detected more often among the LC group, the role of this mutation in progression of fibrosis seems less than that of the BCP mutations. Sequential analysis showed that (1) rapidly progressing cases were positive continuously for double mutations in the BCP with a wild-type precore sequence, and (2) asymptomatic cases with anti-HBe acquired the preC mutation during their clinical course.
CONCLUSIONS: Double mutations in the BCP region at nucleotide 1762/1764 are closely related to progression of chronic liver disease. Acquisition of mutation in the preC region at nucleotide 1896 may contribute to inactivation of chronic liver disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12175631     DOI: 10.1016/s0168-8278(02)00180-0

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  25 in total

1.  High level of hepatitis B virus DNA after HBeAg-to-anti-HBe seroconversion is related to coexistence of mutations in its precore and basal core promoter.

Authors:  Xiao-Mou Peng; Gui-Mei Huang; Jian-Guo Li; Yang-Su Huang; Yong-Yu Mei; Zhi-Liang Gao
Journal:  World J Gastroenterol       Date:  2005-05-28       Impact factor: 5.742

2.  Optimization of competitively differentiated polymerase chain reaction in detection of HBV basal core promoter mutation.

Authors:  Xiao-Mou Peng; Lin Gu; Xue-Juan Chen; Jian-Guo Li; Yang-Su Huang; Zhi-Liang Gao
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

3.  Diwu Yanggan capsule improving liver histological response for patients with HBeAg-negative chronic hepatitis B: a randomized controlled clinical trial.

Authors:  Hanmin Li; Zhihua Ye; Xiang Gao; Lisheng Zhang; Xin Yao; Jianxun Gu; Dingbo Lu; Ming Wan; Lin Xiao; Wangxi Cai; Xuesheng Yan; Binbin Zhao; Yu Wu; Jinrong Zhang
Journal:  Am J Transl Res       Date:  2018-05-15       Impact factor: 4.060

4.  Abnormal immunity and gene mutation in patients with severe hepatitis-B.

Authors:  Jing-Yan Wang; Pei Liu
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

5.  Precore/basal core promoter mutants and hepatitis B viral DNA levels as predictors for liver deaths and hepatocellular carcinoma.

Authors:  Myron J Tong; Lawrence M Blatt; Jia-Horng Kao; Jason Tzuying Cheng; William G Corey
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

6.  A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection.

Authors:  Myron John Tong; Leeyen Hsu; Carlos Hsien; Jia-Horng Kao; Francisco Antonio Durazo; Sammy Saab; Lawrence Mitchell Blatt
Journal:  Hepatol Int       Date:  2010-04-07       Impact factor: 6.047

7.  Novel assay of competitively differentiated polymerase chain reaction for screening point mutation of hepatitis B virus.

Authors:  Xiao-Mou Peng; Xue-Juan Chen; Jian-Guo Li; Lin Gu; Yang-Su Huang; Zhi-Liang Gao
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

8.  Genomic change in hepatitis B virus associated with development of hepatocellular carcinoma.

Authors:  Danbi Lee; Heather Lyu; Young-Hwa Chung; Jeong A Kim; Priya Mathews; Elizabeth Jaffee; Lei Zheng; Eunsil Yu; Young Joo Lee; Soo Hyung Ryu
Journal:  World J Gastroenterol       Date:  2016-06-21       Impact factor: 5.742

9.  Basal core promoter and precore mutations in the hepatitis B virus genome enhance replication efficacy of Lamivudine-resistant mutants.

Authors:  Frank Tacke; Christina Gehrke; Tom Luedde; Albert Heim; Michael P Manns; Christian Trautwein
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

10.  Specific mutations of hepatitis B virus in plasma predict liver cancer development.

Authors:  Shuang-Yuan Kuang; Peta E Jackson; Jin-Bing Wang; Pei-Xing Lu; Alvaro Muñoz; Geng-Sun Qian; Thomas W Kensler; John D Groopman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.